All News

Investigators developed a genetically distinct and non-toxic strain of salmonella called CRC2631 to select and kill cancer cells, which may be able to be tailored to specific patients.

A greater understanding of obesity and its impact on cardiovascular health highlights abdominal obesity, sometimes referred to as visceral adipose tissue (VAT), as a cardiovascular disease risk marker.

Researchers from the University of Pennsylvania School of Medicine have identified additional genetic mutations that strongly predispose otherwise healthy women to peripartum cardiomyopathy (PPCM), a rare condition characterized by weakness of the heart muscle that begins sometime during the final month of pregnancy through 5 months after delivery.

Despite the fact that 98% of the survey respondents said they were aware of PrEP, less than 25% were currently taking it.

The FDA has approved Gemtesa (vibegron; Urovant Sciences) tablets to treat overactive bladder (OAB) with symptoms of urge urinary incontinence (UUI), urgency, and urinary frequency.

For World Immunization Week, Pharmacy Times® interviewed Nurisha Wade, MBA, VP of Global Healthcare Quality & Safety Center of Excellence at US Pharmacopeia (USP), and Farah Towfic, PharmD, MBA, director, CEO of Operations at USP, on USP’s COVID-19 Vaccine Handling Toolkit.

Beattie's Healthmart is known for stellar customer service and its 3 playful, yet protective, dogs.

Pharmacy Times® interviewed Scott J. Knoer, MS, PharmD, FASHP, the EVP and CEO of the American Pharmacists Association, on the Pharmacy and Medically Underserved Area Enhancement Act that was recently introduced in Congress.

The report further showed that drug expenditure in nonfederal hospitals declined 4.6%, while drug spending in home care settings increased 13%, and drug expenditures in nonfederal hospitals spiked in the 3 weeks immediately following the March 8, 2020 lockdown.

The antibiotic fights both resistant enterococcus, streptococcus, and staphylococcus bacteria via a unique mechanism of action, which causes resistance to develop at a very slow pace.

Nocturnal respiratory events, when they either completely or partially block the airways, often cause repeated oxygen desaturations and interrupted sleep in patients with OSA, leading to abnormal nervous system function.

Broadly, the study results showed that if a participant's cognitive ability, physical health, or mental health declined over the course of the 6-month study period, that participant became less cognitively engaged as the tasks increased in difficulty.

Pharmacies cannot prevent shortages, particularly with the complexities of treating COVID-19; however, they can strengthen their ability to prepare their organization to respond to those complexities.

The study found that more than 10% of participants who were previously infected with SARS-CoV-2 (seropositive) became reinfected, compared with new infections in 50% of participants who had not been previously infected (seronegative).

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.

A new service connects community pharmacies with health care systems to support the delivery of health care products and services through crowdsourcing.

Face mask usage may help, and pharmacists can provide other education and guidance about safe and proper use of nonprescription medications.

Oncology experts recommend patients schedule overdue screenings, as pandemic restrictions ease.

This is the first systematic literature review on the association of back pain and mortality.

A CDC panel voted to add a warning label to the vaccine regarding rare cases of cerebral venous sinus thrombosis.

Loncastuximab tesirine-lpyl is a CD19-targeted antibody drug conjugate.

Pharmacists and other clinicians share responsibility for relieving symptoms, preventing transmission, and avoiding complications.

The POETYK PSO-1 and POETYK PSO-2 trials, which evaluated deucravacitinib 6 mg once daily, met both co-primary endpoints versus placebo, with significantly more patients achieving Psoriasis Area and Severity Index (PASI) 75 response and a static Physician's Global Assessment score of clear or almost clear (sPGA 0/1) after 16 weeks of treatment with deucravacitinib.

According to the study authors, the findings suggest a need for greater transparency in health care pricing as well as policies eliminating financial obstacles to catching cancer early.

Individuals who had COVID-19 and recovered had a robust antibody response after the first mRNA vaccine dose, but little immune benefit after the second dose.

The study highlights a new role for pregnancy-associated plasma protein A, known as PAPPA, in gestational diabetes, with translational potential as both a diagnostic tool and therapeutic target.

Novel therapeutics under investigation include CAR T-cell therapies, antibody-drug conjugates, and bispecific antibodies, as well as other unique drugs.

New research findings published in Cell Reports identified a type of immune cells that acts as a major driver of breast cancer growth by preventing the accumulation of a specific protein that induces anti-tumor responses.

The decrease was lower in children under 2 years of age and recovered quickly in that group, but it remained persistent in older children.

B cell activating factor appears to promote antibodies against, and inhibitors of, the missing blood clotting factor that is given to patients with hemophilia A to control their bleeding.